Examination of Clinical Trial Costs and Barriers for Drug Development. E.3.9 Barriers Related to the Globalization of Clinical Research


  • The clinical research footprint is shifting overseas.
  • There are a number of factors, including cost savings and shorter timelines, driving this shift and making it cheaper and easier to conduct trials outside the U.S.
  • Ethical and scientific concerns may arise when conducting studies in other countries.
  • Conducting trials at multiple sites across different countries magnifies the barriers associated with multicenter trials.


View full report


"rpt_erg.pdf" (pdf, 1.89Mb)

Note: Documents in PDF format require the Adobe Acrobat Reader®. If you experience problems with PDF documents, please download the latest version of the Reader®